Beyond insulin: Medi-Cal expands patient access to diabetes supplies

June Voros sprang from her couch as a high-pitched beep warned her that she needed a quick dose of sugar.

Vertex says about 20 patients have started sickle cell therapy; cuts two rare disease programs

Vertex Pharmaceuticals is picking up momentum in its strategy of branching out beyond cystic fibrosis. About 20 patients have had their cells collected for Casgevy

August 2, 2024

High Tide Q2 Revenue Flat to Q1 at C$118.1 Million

High Tide Reports Third Consecutive Quarter of Record Revenue and Adjusted EBITDA of $118.1 Million and $6.6 Million, Respectively The Company Achieved Significant Sequential Improvement

June 15, 2023

BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology – Biotech Investments

EQS-News: BRAIN Biotech AG / Key word(s): Contract BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology 31.10.2024

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.